MLNSX
Price
$27.90
Change
+$0.13 (+0.47%)
Updated
Sep 26 closing price
Net Assets
350.82M
RNPEX
Price
$71.60
Change
+$0.37 (+0.52%)
Updated
Sep 26 closing price
Net Assets
161.39B
Interact to see
Advertisement

MLNSX vs RNPEX

Header iconMLNSX vs RNPEX Comparison
Open Charts MLNSX vs RNPEXBanner chart's image
Morgan Stanley Instl Glbl Concntr R6
Price$27.90
Change+$0.13 (+0.47%)
VolumeN/A
Net Assets350.82M
American Funds New Perspective R4
Price$71.60
Change+$0.37 (+0.52%)
VolumeN/A
Net Assets161.39B
MLNSX vs RNPEX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
MLNSX vs. RNPEX commentary
Sep 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLNSX is a Hold and RNPEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNPEX has more cash in the bank: 161B vs. MLNSX (351M). RNPEX pays higher dividends than MLNSX: RNPEX (0.48) vs MLNSX (0.20). MLNSX was incepted earlier than RNPEX: MLNSX (9 years) vs RNPEX (23 years). MLNSX (9.05) is less costly to investors than RNPEX (0.76). MLNSX is a more actively managed with annual turnover of: 43.00 vs. RNPEX (24.00). RNPEX has a lower initial minimum investment than MLNSX: RNPEX (250) vs MLNSX (5000000). MLNSX annual gain was more profitable for investors over the last year : 18.54 vs. RNPEX (10.73). MLNSX return over 5 years is better than : 93.13 vs. RNPEX (40.31).
MLNSXRNPEXMLNSX / RNPEX
Total Expense Ratio0.950.76125%
Annual Report Gross Expense Ratio9.050.761,191%
Fund Existence9 years23 years-
Gain YTD18.87517.550108%
Front LoadN/AN/A-
Min. Initial Investment50000002502,000,000%
Min. Initial Investment IRAN/AN/A-
Net Assets351M161B0%
Annual Yield % from dividends0.200.4842%
Returns for 1 year18.5410.73173%
Returns for 3 years99.2561.36162%
Returns for 5 years93.1340.31231%
Returns for 10 yearsN/A110.48-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CTMX2.900.06
+2.11%
CytomX Therapeutics
SOLV71.370.91
+1.29%
Solventum Corp
EFSC58.840.22
+0.38%
Enterprise Financial Services Corp
WSBK9.560.03
+0.31%
Winchester Bancorp Inc
SPHL0.46-0.01
-2.28%
Springview Holdings Ltd